スタッフ紹介
診療内容
病気と向き合う
よくあるご質問
トピックス
リンク集
西日本泌尿器科
文献
文献
原著
総説
症例
著書
その他
         
年度を選択
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
原 著
2016年
 
 
 
表 題
著者名
誌 名
An Open-Label, Randomized Phase II Trial of Personalized Peptide Vaccination in Patients with Bladder Cancer that Progressed after Platinum-Based Chemotherapy. Noguchi M, Matsumoto K, Uemura H, Arai G, Eto M, Naito S, Ohyama C, Nasu Y, Tanaka M, Moriya F, Suekane S, Matsueda S, Komatsu N, Sasada T, Yamada A, Kakuma T, Itoh K: Clin Cancer Res 22 (1): 54-60, 2016
Taxane Chemotherapy for Hormone-Naive Prostate Cancer with Its Expanding Role as Breakthrough Strategy. Shiota M, Yokomizo A, Eto M: Front Oncol 5 :304, 2016
Prognostic Significance of Preoperative Urine Cytology in Low-grade Non-muscle-invasive Bladder Cancer. Kiyoshima K, Akitake M, Shiota M, Takeuchi A, Takahashi R, Inokuchi J, Tatsugami K, Yokomizo A, Eto M: Anticancer Res 36 (2): 799-802, 2016
Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone-sensitive prostate cancer. Shiota M, Eto M. Int J Urol 23 (5): 360-369, 2016
CXCL10 and CCL2 mRNA expression in monocytes is inversely correlated with the HLA-DR lower fraction of monocytes in patients with renal cell carcinoma. Motoshima T, Komohara Y, Horlad H, Tsukamoto H, Fujita M, Saito Y, Tanoue K, Kasejima Y, Sugiyama Y, Kawano Y, Nishimura Y, Takeya M, Eto M: Oncol Lett 11 (3): 1911-1916, 2016
The subclassification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery. Bigot P, Bernhard JC, Gill IS, Vuong NS, Verhoest G, Flamand V, Reix B, Suer E, Gokce I, Beauval JB, Nouhaud FX, Eto M, Baco E, Matsugasumi T, Chowaniec Y, Rigaud J, Lenormand C, Pfister C, Hetet JF, Ploussard G, Roupret M, Leon P, Bakri AE, Larre S, Tillou X, Doerfler A, Descazeaud A, Koutlidis N, Schneider A, Sebe P, Ingels A, Azzouzi AR, Soulie M, Mejean A, Bensalah K, Patard JJ; members of the Kidney Cancer group of the CCAFU. World J Urol 34 (3): 347-352, 2016
Impact of multimodal treatment on prognosis for patients with metastatic upper urinary tract urothelial cancer: Subanalysis of the multi-institutional nationwide case series study of the Japanese Urological Association. Inokuchi J, Naito S, Fujimoto H, Hara T, Sakura M, Nishiyama H, Miyazaki J, Kikuchi E, Hinotsu S, Koie T, Ohyama C; Cancer Registration Committee of the Japanese Urological Association:

Int J Urol 23 (3): 224-230, 2016


Infiltration of tumor-associated macrophages is involved in CD44 expression in clear cell renal cell carcinoma. Ma C, Komohara Y, Ohnishi K, Shimoji T, Kuwahara N, Sakumura Y, Matsuishi K, Fujiwara Y, Motoshima T, Takahashi W, Yamada S, Kitada S, Fujimoto N, Nakayama T, Eto M, Takeya M: Cancer Sci 107 (5): 700-707, 2016
Diversity in treatment modalities of Stage II/III urothelial cancer in Japan: sub-analysis of the multi-institutional national database of the Japanese Urological Association. Koie T, Ohyama C, Fujimoto H, Nishiyama H, Miyazaki J, Hinotsu S, Kikuchi E, Sakura M, Inokuchi J, Hara T; Cancer Registration Committee of the Japanese Urological Association, Ohyama C, Nishiyama H, Fujisawa M, Uemura H, Fujimoto H, Suzuki K, Eto M, Hara I, Matsubara A, Nonomura N, Nakanishi H, Koie T, Kanayama H, Miki T, Fukumori T, Naito S; Cancer Registration Committee of the Japanese Urological Association. Jpn J Clin Oncol 46 (5): 468-474, 2016
Antitumor activity of recombinant Bacille Calmette-Guerin secreting interleukin-15-Ag85B fusion protein against bladder cancer. Takeuchi A, Eto M, Tatsugami K, Shiota M, Yamada H, Kamiryo Y, Dejima T, Kashiwagi E, Kiyoshima K, Inokuchi J, Takahashi R, Yokomizo A, Ohara N, Yoshikai Y. Int Immunopharmacol 35: 327-331, 2016
Aldehyde dehydrogenase 2 (ALDH2) and alcohol dehydrogenase 1B (ADH1B) polymorphisms exacerbate bladder cancer risk associated with alcohol drinking: gene-environment interaction. Masaoka H, Ito H, Soga N, Hosono S, Oze I, Watanabe M, Tanaka H, Yokomizo A, Hayashi N, Eto M, Matsuo K. Carcinogenesis 37 (6): 583-588, 2016
The prognostic impact of serum testosterone during androgen-deprivation therapy in patients with metastatic prostate cancer and the SRD5A2 polymorphism. Shiota M, Fujimoto N, Yokomizo A, Takeuchi A, Kashiwagi E, Dejima T, Kiyoshima K, Inokuchi J, Tatsugami K, Eto M. Prostate Cancer Prostatic Dis 19 (2): 191-196, 2016
Prognosis of metastatic renal cell carcinoma with first-line interferon-α therapy in the era of molecular-targeted therapy. Kawano Y, Takahashi W, Eto M, Kamba T, Miyake H, Fujisawa M, Kamai T, Uemura H, Tsukamoto T, Azuma H, Matsubara A, Nishimura K, Nakamura T, Ogawa O, Naito S. Cancer Sci 107 (7): 1013-1017, 2016
Equol inhibits prostate cancer growth through degradation of androgen receptor by S-phase kinase-associated protein 2. Itsumi M, Shiota M, Takeuchi A, Kashiwagi E, Inokuchi J, Tatsugami K, Kajioka S, Uchiumi T, Naito S, Eto M, Yokomizo A. Cancer Sci 107 (7): 1022-1028, 2016
Effects of switching from alpha-blocker to tadalafil in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (KYU-PRO STUDY). Miyazato M, Oshiro T, Saito S, Takahashi R, Eto M, Nishi H, Fujimoto N,
Sumino Y, Miyata H, Arai K, Kinjo T:
Nishinihon J Urol 78: 398-405, 2016
Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan. Takahashi S, Hamasuna R, Yasuda M, Ishikawa K, Hayami H, Uehara S, Yamamoto S, Minamitani S, Kadota J, Iwata S, Kaku M, Watanabe A, Sato J, Hanaki H, Masumori N, Kiyota H, Egawa S, Tanaka K, Arakawa S, Fujisawa M, Kumon H, Wada K, Kobayashi K, Matsubara A, Matsumoto T, Eto M, Tatsugami K, Kuroiwa K, Ito K, Hosobe T, Hirayama H, Narita H, Yamaguchi T, Ito S, Sumii T, Kawai S, Kanokogi M, Kawano H, Chokyu H, Uno S, Monden K, Kaji S, Kawahara M, Takayama K, Ito M, Yoshioka M, Kano M, Konishi T, Kadena H, Nishi S, Nishimura H, Yamauchi T, Maeda S, Horie M, Ihara H, Matsumura M, Shirane T, Takeyama K, Akiyama K, Takahashi K, Ikuyama T, Inatomi H, Yoh M: J Infect Chemother 22 (9): 581-586, 2016
Smoking effect on secondary bladder cancer after external beam radiotherapy for prostate cancer. Shiota M, Yokomizo A, Takeuchi A, Inokuchi J, Tatsugami K, Ohga S, Sasaki T, Nakamura K, Honda H, Eto M Jpn J Clin Oncol 46 (10): 952-957, 2016
C5a receptor expression is associated with poor prognosis in urothelial cell carcinoma patients treated with radical cystectomy or nephroureterectomy. Wada Y, Maeda Y, Kubo T, Kikuchi K, Eto M, Imamura T: Oncol Lett 12 (5): 3995-4000, 2016
Co-introduction of a steroid with docetaxel chemotherapy for metastatic castration-resistant prostate cancer affects PSA flare. Shiota M, Yokomizo A, Takeuchi A, Kiyoshima K, Inokuchi J, Tatsugami K, Shiga KI, Koga H, Yamaguchi A, Naito S, Eto M: BJU Int 118 (6): 880-884, 2016
ロボット手術時代における前立腺癌リンパ節転移予測ノモグラムの妥当性. 猪口淳一、波止 亮、清島圭二郎、武内在雄、塩田真己、高橋良輔、立神勝則
横溝 晃、江藤正俊
西日泌尿 78 (9): 451-456, 2016
Actions of cAMP on calcium sensitization in human detrusor smooth muscle contraction. Hayashi M, Kajioka S, Itsumi M, Takahashi R, Shahab N, Ishigami T, Takeda M, Masuda N, Yamaguchi A, Naito S: BJU Int 117 (1): 179-191, 2016
Randomized Controlled Study of the Efficacy, Safety and Quality of Life with Low Dose bacillus Calmette-Guerin Instillation Therapy for Nonmuscle Invasive Bladder Cancer. Yokomizo A, Kanimoto Y, Okamura T, Ozono S, Koga H, Iwamura M, Tanaka H, Takahashi S, Tsushima T, Kanayama HO, Akaza H, Shinohara N, Mugiya S, Nomata K, Nakamura T, Naito S: J Urol 195 (1): 41-46, 2016
Apparent diffusion coefficient: An associative factor for recurrence after nephrectomy in localized renal cell carcinoma. Nishie A, Kakihara D, Asayama Y, Ishigami K, Ushijima Y, Takayama Y, Okamoto D, Fujita N, Morita K, Kubo Y, Inokuchi J, Honda H: J Magn Reson Imaging 43 (1): 166-172, 2016
The Expression of Ubiquitous Mitochondrial Creatine Kinase Is Downregulated as Prostate Cancer Progression. Amamoto R, Uchiumi T, Yagi M, Monji K, Song Y, Oda Y, Shiota M, Yokomizo A, Naito S, Kang D: J Cancer 7 (1): 50-59, 2016
Actions of cAMP on calcium sensitization in human detrusor smooth muscle contraction. Hayashi M, Kajioka S, Itsumi M, Takahashi R, Shahab N, Ishigami T, Takeda M, Masuda N, Yamaguchi A, Naito S: BJU Int 117 (1): 179-191, 2016
Nerve growth factor facilitates redistribution of adrenergic and non-adrenergic non-cholinergic perivascular nerves injured by phenol in rat mesenteric resistance arteries. Yokomizo A, Takatori S, Hashikawa-Hobara N, Goda M, Kawasaki H: Eur J Pharmacol 770: 110-116, 2016
Potential Role for YB-1 in Castration-Resistant Prostate Cancer and Resistance to Enzalutamide Through the Androgen Receptor V7. Shiota M, Fujimoto N, Imada K, Yokomizo A, Itsumi M, Takeuchi A, Kuruma H, Inokuchi J, Tatsugami K, Uchiumi T, Oda Y, Naito S: J Natl Cancer Inst 108 (7), 2016
Association Study of a Functional Variant on ABCG2 Gene with Sunitinib-Induced Severe Adverse Drug Reaction. Low SK, Fukunaga K, Takahashi A, Matsuda K, Hongo F, Nakanishi H, Kitamura H, Inoue T, Kato Y, Tomita Y, Fukasawa S, Tanaka T, Nishimura K, Uemura H, Hara I, Fujisawa M, Matsuyama H, Hashine K, Tatsugami K, Enokida H, Kubo M, Miki T, Mushiroda T: PLoS One 11 (2), 2016
Renal cell carcinoma with rhabdoid-like features lack intracytoplasmic inclusion bodies and show aggressive behavior. Sugimoto M, Kohashi K, Kuroiwa K, Abe T, Yamada Y, Shiota M, Imada K, Naito S, Oda Y: Virchows Arch 468 (3): 357-367, 2016
Epithelial to Mesenchymal Transition in Clear Cell Renal Cell Carcinoma with Rhabdoid Features. Sugimoto M, Kohashi K, Itsumi M, Shiota M, Abe T, Yamada Y, Kuroiwa K, Naito S, Oda Y: Pathobiology 83 (6): 277-286, 2016
Surface vacuolar ATPase in ameloblastoma contributes to tumor invasion of the jaw bone. Yoshimoto S, Morita H, Matsubara R, Mitsuyasu T, Imai Y, Kajioka S, Yoneda M, Ito Y, Hirofuji T, Nakamura S, Hirata M: Int J Oncol 48 (3): 1258-1270, 2016
Laparoscopic Versus Open Nephroureterectomy in Muscle-Invasive Upper Tract Urothelial Carcinoma: Subanalysis of the Multi-Institutional National Database of the Japanese Urological Association. Miyazaki J, Nishiyama H, Fujimoto H, Ohyama C, Koie T, Hinotsu S, Kikuchi E, Sakura M, Inokuchi J, Hara T: J Endourol 30 (5): 520-525, 2016
Little Impact on Renal Function in Advanced Renal Cell Carcinoma Patients Treated with Sorafenib--Analyses of Postmarketing Surveillance in Japan in over 3,200 Consecutive Cases. Oya M, Tatsugami K, Kabu K, Adachi M, Ito Y, Akaza H: Gan To Kagaku Ryoho 43 (5): 559-569, 2016
Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria. Katayama H, Kurokawa Y, Nakamura K, Ito H, Kanemitsu Y, Masuda N, Tsubosa Y, Satoh T, Yokomizo A, Fukuda H, Sasako M: Surg Today 46 (6): 668-685, 2016
Amide proton transfer (APT) magnetic resonance imaging of prostate cancer: comparison with Gleason scores. Takayama Y, Nishie A, Sugimoto M, Togao O, Asayama Y, Ishigami K, Ushijima Y, Okamoto D, Fujita N, Yokomizo A, Keupp J, Honda H: MAGMA 29 (4): 671-679, 2016
Functional coupling of TRPV4 channels and BK channels in regulating spontaneous contractions of the guinea pig urinary bladder. Isogai A, Lee K, Mitsui R, Hashitani H: Pflugers Arch 468 (9): 1573-1585, 2016
Role of PTHrP and Sensory Nerve Peptides in Regulating Contractility of Muscularis Mucosae and Detrusor Smooth Muscle in the Guinea Pig Bladder. Lee K, Mitsui R, Kajioka S, Naito S, Hashitani H: J Urol 196 (4): 1287-1294, 2016
 
         
原著
総説
症例
著書
その他
ページの先頭へ戻る
〒812-8582 福岡市東区馬出3-1-1 九州大学大学院医学研究院泌尿器科学分野 092-642-5615(外来)
九州大学大学院医学研究院泌尿器科学分野 サイトマップ トップページ